“Vascular Response to Everolimus- and Biolimus-Eluting Coronary Stents Versus Everolimus-Eluting Bioresorbable Scaffolds – an Optical Coherence Tomography Substudy of the EVERBIO II Trial”. 2016. Swiss Medical Weekly 146 (0102): w14274. https://doi.org/10.4414/smw.2016.14274.